Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV005089573 | SCV005848232 | likely pathogenic | not provided | 2024-08-14 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in abnormal protein length as the last 105 amino acids are replaced with 31 different amino acids, and other similar variants have been reported in HGMD; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20301648, 33235754, 38003924, 27943079, 17846997) |
Labcorp Genetics |
RCV005222754 | SCV005863055 | uncertain significance | Aicardi-Goutieres syndrome 1; Chilblain lupus 1; Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations | 2024-07-12 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp210Serfs*32) in the TREX1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 105 amino acid(s) of the TREX1 protein. This variant is present in population databases (rs753237990, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with Aicardi-Goutieres syndrome (PMID: 17846997, 27943079). ClinVar contains an entry for this variant (Variation ID: 126392). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV000114333 | SCV000147902 | not provided | Aicardi-Goutieres syndrome 1 | no assertion provided | literature only |